Advanced in Peptic Ulcer

Halina Lach-Cichoz

8 Jaczewskiego Str, 
Lublin, LU, PL 
Advanced in Peptic Ulcer
8 Jaczewskiego Str, 
Lublin, LU, PL 
OverviewLocationsClinical Research

Overview

Halina Lach-Cichoz practices in Lublin, Poland. Ms. Lach-Cichoz is rated as an Advanced expert by MediFind in the treatment of Peptic Ulcer. Her top areas of expertise are Alcoholic Cirrhosis, Cirrhosis, Peptic Ulcer, Non-Alcoholic Fatty Liver Disease, and Endoscopy.

Her clinical research consists of co-authoring 75 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 3 articles in the study of Peptic Ulcer.

Gender
Female

Locations

8 Jaczewskiego Str, Lublin, LU 20090, Poland
Other Locations
Jaczewski Str, 820-954, Lublin, LU 20954, Poland

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Phase 3, Multicenter, Open-Label Extension Study to Evaluate the Long Term Efficacy and Safety of Mirikizumab in Patients With Moderately to Severely Active Ulcerative Colitis LUCENT 3
A Phase 3, Multicenter, Open-Label Extension Study to Evaluate the Long Term Efficacy and Safety of Mirikizumab in Patients With Moderately to Severely Active Ulcerative Colitis LUCENT 3
Enrollment Status: Active_not_recruiting
Publish Date: October 10, 2025
Intervention Type: Drug
Study Drug: Mirikizumab
Study Phase: Phase 3
A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled, Dose-finding Study to Evaluate the Efficacy and Safety of IMU-838 for Induction and Maintenance Therapy in Moderate-to-severe Ulcerative Colitis
A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled, Dose-finding Study to Evaluate the Efficacy and Safety of IMU-838 for Induction and Maintenance Therapy in Moderate-to-severe Ulcerative Colitis
Enrollment Status: Terminated
Publish Date: March 05, 2024
Intervention Type: Drug
Study Drug: IMU-838
Study Phase: Phase 2
Assessment of the Efficacy of Single-strain Probiotics in Patients With Irritable Bowel Syndrome - a Randomized Double-blind Placebo-controlled Study
Assessment of the Efficacy of Single-strain Probiotics in Patients With Irritable Bowel Syndrome - a Randomized Double-blind Placebo-controlled Study
Enrollment Status: Completed
Publish Date: July 07, 2023
Intervention Type: Dietary supplement
Study Phase: Not Applicable
View 2 Less Clinical Trials

75 Total Publications

Is There a Diagnostic Miracle on the Horizon? Emerging Biomarkers in MASLD.
Is There a Diagnostic Miracle on the Horizon? Emerging Biomarkers in MASLD.
Journal: Journal of clinical medicine
Published: August 02, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Lach-Cichoz's expertise for a condition
ConditionClose
    View All 36 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile